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states that ‘it would be unethical to withhold sedation
and anesthesia when necessary’ and ‘more harm may be
inflicted if necessary treatment is withheld’. As a corol-
lary to this statement, based on current evidence and
considering the advantages of breast-feeding to both the
mother and the infant, the use of short-acting sedative
premedication for the nursing mother may be consid-
ered (albeit with caution as with any other medication).
Further research in measuring the parent drug and any
active metabolites in the infant blood and urine would
be reassuring in determining which maternally adminis-
trated drugs would deliver minimal to absent exposure
to the infant (5). We certainly remain concerned over
any possible effect of any drug transmitted via breast
milk (5).
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Pain score guided morphine titration is risky and
inappropriate
SIR—We read with great interest the recent article by
Bernard et al. (1) that described, evaluated, and pro-
posed a morphine titration protocol for children in the
postanesthesia care unit (PACU). The authors con-
cluded the efficacy and safety of their titration protocol
based on reductions in pain scores to <30/100 and the
purported nonserious nature of side effects in their sam-
ple of 103 children. However, we are compelled to raise
several important concerns regarding their proposed
protocol and findings that might, in contrast, suggest
potentially risky and inappropriate morphine titration
practices.
First, the use of pain score cut-points to titrate medi-
cations should be regarded as inappropriate. Experts in
assessment now largely concur that pain scores alone
cannot convey the information necessary to effectively
treat pain (2). This is particularly true of behavioral
pain scores which convey distress signals and require
differentiation between pain, anxiety, hunger, or, most
importantly, physiologic compromise. Interpreting self-
report scores poses its own challenges. We previously
found that although self-reported numeric pain scores
>4/10 were statistically associated with children’s per-
ceived need for medicine; there is wide variability in the
scores children associate with analgesia need, percep-
tions of pain severity, and pain relief (2,3). Given such
variability, had we applied our own cut-point to our
sample, we would have over-treated 42% of children
compared to their stated needs. These data and others
highlight the inappropriateness of pain score-based
algorithms to achieve clinically relevant analgesia.
More importantly, data suggest an increase in
opioid-related adverse events and death following
implementation of pain score-guided algorithms and
guidelines (4,5). Bernard et al.’s data highlight this risk
as 20% of their sample experienced excessive sedation
(the precursor to respiratory depression), one child
became bradypneic, and 2 experienced oxygen desatura-
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tion. This incidence of sedation is not surprising, given
that some children in their sample had received as much
as 350 lgkg1. Of note, several had received multiple
doses of morphine, yet continued to have pain scores
above the target at the end of the observation period. In
these cases, children experienced both ineffective (based
on study definitions) and risky outcomes, thereby
emphasizing the pitfalls of a titration-to-pain-score
protocol.
Next, Bernard et al.’s proposed time interval for
assessment and morphine titration (i.e., every 5 min)
may compound the risk for children given the known
lag between plasma and brain concentrations of the
drug, and, as the authors acknowledge, the accumula-
tion of morphine-6-glucuronide (6,7). Pharmacokinetic
models and clinical studies suggest that the maximum
benefits and risks of morphine occur with peak brain
concentrations, which are on average, 125–166 min after
dosing (6,7). It is, therefore, quite possible that children
in the Bernard study could have experienced additional
or progressive respiratory decline after their 90-min
observation period.
The high number of children with oversedation in the
Bernard study cannot be overemphasized and, in fact,
should have been included in their adverse events table.
The study protocol required discontinuation of titration
for Ramsey scores of 5 or 6 (defined as ‘Patient exhibits
a sluggish response to glabellar tap or loud auditory
stimulus’ and ‘Patient exhibits no response’), and 20%
achieved this excessive level during the 90-min period.
We question whether even a Ramsey score of 4 (i.e.,
‘Brisk response to a light glabellar tap or auditory stim-
ulus’) would imply a safe level of narcosis – particularly
just prior to PACU discharge. Based on procedural
sedation data (8) and other recommendations (9), we
suggest instead consideration of both arousability and
wakefulness (i.e., ability to stay awake during assess-
ment or conversation) to promote safe opioid use in
children. The Pasero Opioid-induced Sedation Scale
(POSS) combines these observations along with treat-
ment suggestions into a four-point tool (9). A POSS
level 3 (i.e., ‘Frequently drowsy, arousable, drifts off to
sleep during conversation’) is considered unacceptable
and requires increased respiratory monitoring and
reevaluation of opioid dosing. Although published data
have not yet described clinical outcomes following POSS
implementation, we believe that compared to Ramsey
arousability scores alone, such combined assessments
may promote safer opioid decisions.
Regulatory agencies and the Anesthesia Patient Safety
Foundation (APSF) have emphasized the need for safe
opioid practices. Among other recommendations, the
Joint Commission (USA) recently suggested (i) avoiding
rapid dose escalation above routine dose levels; (ii)
taking extra precautions when transferring patients
between units or when discharging patients to home as
‘drug levels may reach peak concentrations during [or
after] transport’; and (iii) ‘avoid using opioids to meet
an arbitrary pain rating’ (10). Anesthesia providers are
ideally positioned to take the lead on safe opioid prac-
tices, and must therefore carefully consider the risk-ben-
efit tradeoffs of their pain management strategies.
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Night terrors and emergence delirium
SIR—Night terrors belong to the parasomnia group of
sleep disorders. They occur during the first third of
night-time sleep during arousal from stage 3 of the
nonrapid eye movement phase (1). Night terrors are
characterized by sudden arousal followed by screaming
and crying. A key feature is that the subject will be
inconsolable and will not want to be touched or com-
forted. Additionally, they will act afraid, agitated, and
anxious (1). Such an episode may last for up to 30 min,
and afterward, the subject will have no recollection of
the episode. This phenomenon has a prevalence of
1–6.5% in children aged 4–12 years (1).
Children suffering emergence delirium (ED) exhibit
psychomotor agitation, hallucinations, misperceptions,
and fluctuating behavior in the immediate postoperative
period following anesthesia (2). The key characteristics
of ED are nonpurposeful movement, nonresponsivity,
and averted or stared eyes (2). As with night terrors,
inconsolability is also a key behavior in children who dis-
play ED (2). Rates of ED vary from 25% to 80% in chil-
dren, depending on the evaluation system being used (3).
The similarity in the clinical presentation of night
terrors and ED as well as evidence from electroencepha-
lograph patterns suggests these two phenomena may be
linked (4). Similarly to how car sickness is predictive of
postoperative vomiting, night terrors may be predictive
of ED. Anesthesia may then be altered to decrease the
incidence of ED in those children who have a history of
night terrors.
We undertook an observational audit over a period
of 4 months to determine the relationship between
night terrors and ED. Healthy children aged 15 years
and younger undergoing anesthesia for adenoidectomy,
(adeno) tonsillectomy, and myringotomy procedures
were included in the study. Multiple surgeons and anes-
thesiologists were involved in the procedures, and
although the choice of anesthetic was left to the discre-
tion of the anesthesiologist, total intravenous anesthesia
was not used in this cohort. On admission to hospital,
parents were asked whether their child ever woke in a
distressed state where they were difficult to console. ED
was determined in the postanesthesia care unit using
the Pediatric Anesthesia Emergence Delirium (PAED)
scale approximately 5 min after the patient awoke from
anesthesia. A score equal to or greater than 10 was
used to define ED. A comparison in the rate of ED
when using a PAED scale score of 12 was also made,
as this higher threshold has a greater sensitivity at
detecting ED. Additional analyses were performed in
which children administered clonidine were removed
because this drug has been found to reduce the inci-
dence of ED (5). All anesthesia was maintained with
sevoflurane (and an opioid), and no other medications
apart from clonidine were given to decrease the risk of
ED. Ethics approval was received from the University
of Auckland Human Participants Ethics Committee.
There were 406 patients included in this prospective
observational study; those suffering pain were excluded
leaving sufficient data for analysis from 330 (age
4.81 years SD 3.72 years, weight 22.61 kg SD 13.00 kg)
children. A total of 66 children were administered cloni-
dine 0.29–5.56 mcgkg1 during the surgical procedure.
There were 82 children who experienced ED when using
a PAED scale score ≥10, and 53 when using a PAED
scale score ≥12; 149 children had a history of night ter-
rors. The positive predictive values (PPVs) and negative
predictive values (NPVs) for the correlation between
night terrors and ED can be seen in Table 1.
Table 1 PPVs and NPVs for the correlation between night terrors and ED when using a PAED scale score of ≥10 or 12 to define ED and includ-
ing or excluding clonidine
Including clonidine Excluding clonidine
PAED ≥ 10 PAED ≥ 12 PAED ≥ 10 PAED ≥ 12
PPV 26.8% (19.9–34.7%) 16.1% (10.6–23.0%) 26.1% (18.2–35.3%) 18.9% (12.1–27.5%)
NPV 76.8% (70.0–82.7%) 84.0% (77.8–89.0%) 77.8% (70.4–84.1%) 85.0% (78.3–90.2%)
The 95% confidence interval for each value is indicated.
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